Eventide Asset Management - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 54 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2014$1,123,000
+7.2%
30,0000.0%0.12%
-15.8%
Q3 2014$1,048,000
-25.0%
30,0000.0%0.15%
-23.2%
Q2 2014$1,397,000
-33.3%
30,000
-55.8%
0.19%
-41.5%
Q1 2014$2,094,000
+208.8%
67,800
+129.1%
0.32%
+55.5%
Q4 2013$678,00029,6000.21%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders